Quercetin suppresses glomerulosclerosis and TGF-β signaling in a rat model

被引:16
|
作者
Liu, Yifan [1 ]
Dai, Enlai [1 ]
Yang, Jing [2 ]
机构
[1] Gansu Univ Chinese Med, Cooperat Chinese & Western Med Dept, 10 East Dingxi Rd, Lanzhou 730000, Gansu, Peoples R China
[2] Lanzhou Univ, Hosp 2, Dept Children Glomerular Dis, Lanzhou 730000, Gansu, Peoples R China
基金
中国国家自然科学基金;
关键词
quercetin; glomerulosclerosis; transforming growth factor-beta signaling pathway; ADRIAMYCIN-INDUCED GLOMERULOSCLEROSIS; PODOCYTE; EXPRESSION; INJURY; SUPPLEMENTATION; PROTECTS; PROGRESSION; ACTIVATION; APOPTOSIS; PATHWAYS;
D O I
10.3892/mmr.2019.10118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The transforming growth factor-beta (TGF-beta) signaling pathway is an important regulatory pathway in renal fibrosis and is abnormally activated in glomerulosclerosis. Quercetin is a common Chinese herbal medicine and has been reported to inhibit TGF-beta signaling pathway activation. In the present study a glomerulosclerosis rat model was constructed and mice were treated with different concentrations of quercetin. Biochemical parameters, pathological indices and expression levels of TGF-beta signaling pathway-associated proteins were detected using immunohistochemistry and western blotting. It was demonstrated that quercetin significantly improved physiological indices and altered the expression levels of TGF-beta signaling pathway-associated proteins in rats with glomerulosclerosis. In conclusion, quercetin can regulate the TGF-beta signaling pathway and reduce the progression of glomerulosclerosis.
引用
收藏
页码:4589 / 4596
页数:8
相关论文
共 50 条
  • [21] Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts
    Tang, Bing
    Zhu, Bin
    Liang, Yueying
    Bi, Liangkuan
    Hu, Zhicheng
    Chen, Bin
    Zhang, Kai
    Zhu, Jiayuan
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2011, 303 (08) : 563 - 572
  • [22] Pentabromophenol suppresses TGF-β signaling by accelerating degradation of type II TGF-β receptors via caveolae-mediated endocytosis
    Chen, Chun-Lin
    Yang, Pei-Hua
    Kao, Yu-Chen
    Chen, Pei-Yu
    Chung, Chih-Ling
    Wang, Shih-Wei
    SCIENTIFIC REPORTS, 2017, 7
  • [23] The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling
    Lee, Jason D.
    Hempel, Nadine
    Lee, Nam Y.
    Blobe, Gerard C.
    CARCINOGENESIS, 2010, 31 (02) : 175 - 183
  • [24] Pentabromophenol suppresses TGF-β signaling by accelerating degradation of type II TGF-β receptors via caveolae-mediated endocytosis
    Chun-Lin Chen
    Pei-Hua Yang
    Yu-Chen Kao
    Pei-Yu Chen
    Chih-Ling Chung
    Shih-Wei Wang
    Scientific Reports, 7
  • [25] Involvement of BMP-2, TGF-β2 and TGF-β3 Signaling in Initial and Early Stages of Heterotopic Ossification in a rat Experimental Model
    Suutre, S.
    Toom, A.
    Arend, A.
    Selstam, G.
    SCANDINAVIAN JOURNAL OF LABORATORY ANIMAL SCIENCE, 2010, 37 (01) : 31 - 40
  • [26] The plasticity of TGF-β signaling
    Celliere, Geraldine
    Fengos, Georgios
    Herve, Marianne
    Iber, Dagmar
    BMC SYSTEMS BIOLOGY, 2011, 5
  • [27] TGF-β signaling in chondrocytes
    Li, TF
    O'Keefe, RJ
    Chen, D
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 681 - 688
  • [28] TGF-β signaling in fibrosis
    Biernacka, Anna
    Dobaczewski, Marcin
    Frangogiannis, Nikolaos G.
    GROWTH FACTORS, 2011, 29 (05) : 196 - 202
  • [29] RIPK4 suppresses the TGF-β1 signaling pathway in HaCaT cells
    Dincer, Tuba
    Er, Asiye Busra Boz
    Er, Idris
    Toraman, Bayram
    Yildiz, Gokhan
    Kalay, Ersan
    CELL BIOLOGY INTERNATIONAL, 2020, 44 (03) : 848 - 860
  • [30] Bioflavonoid Galangin Suppresses Hypertrophic Scar Formation by the TGF-β/Smad Signaling Pathway
    Ru, Zha
    Hu, Ying
    Huang, Shenghua
    Bai, Li
    Zhang, Kun
    Li, Yue
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021